← State exam

94. Mesenteric venous thrombosis

High yield

Clot in the superior mesenteric vein causes congested, swollen bowel; most respond to heparin, surgery if bowel dies.

Exam Prep · State examSurgery · General surgerySurgery · Emergency and trauma

1. Definition

  • Mesenteric venous thrombosis (MVT) → thrombosis of the mesenteric veins (mostly the superior mesenteric vein, SMV), which blocks venous return from the bowel and can cause venous infarction
  • Primary (idiopathic) → no cause found (now under 10% with modern testing)
  • Secondary → a known prothrombotic, local or inflammatory cause (over 90%)
  • Forms → acute, subacute (weeks to months of vague pain), chronic (found by chance or with portal hypertension)
  • Arterial AMI → question 93; NOMI → question 95

2. Epidemiology

  • About 5–15% of all mesenteric ischaemia
  • Younger patients than arterial AMI → mean age about 45–60
  • Men and women about equal
  • SMV involved in over 90%; inferior mesenteric vein in only 5–10%
  • Often extends into the portal and splenic veins
  • 30-day mortality about 10–30% (much lower than arterial AMI); about 70% present acutely
  • Recurrence up to 25% (mostly in the first 30 days) without anticoagulation; about 3% with it

3. Aetiology and risk factors

  • Virchow's triad → stasis, vessel wall injury, hypercoagulability

Thrombophilia (found in 60–70%)

  • Inherited → factor V Leiden, prothrombin G20210A mutation, protein C, protein S or antithrombin deficiency
  • Acquired → myeloproliferative neoplasms (polycythaemia vera, essential thrombocythaemia; JAK2 V617F mutation), antiphospholipid syndrome, malignancy, oral contraceptive pill, pregnancy, hyperhomocysteinaemia, paroxysmal nocturnal haemoglobinuria, heparin-induced thrombocytopenia

Local causes

  • Intra-abdominal inflammation → pancreatitis, appendicitis, diverticulitis, inflammatory bowel disease, abscess, cholangitis
  • Surgery and trauma → splenectomy (most typical), bariatric surgery (sleeve gastrectomy), portocaval procedures, abdominal trauma
  • Venous stasis → portal hypertension and cirrhosis, heart failure, obesity, abdominal compartment syndrome
  • Compression → tumours (pancreas), nodes

Other

  • Dehydration, infection (CMV, COVID-19), nephrotic syndrome

4. Pathogenesis

  1. Thrombus forms in small venous arcades (peripheral, e.g. in inflammation) or in the main SMV (central, e.g. in thrombophilia) and spreads
  2. Venous outflow blocked → bowel and mesentery become congested, oedematous and haemorrhagic (dark red to purple, thick wall)
  3. Fluid and blood leak into the wall, lumen and peritoneum → bloody ascites, hypovolaemia
  4. Rising pressure in the wall → arterial inflow falls (secondary arterial spasm) → haemorrhagic infarction
  5. Necrosis → perforation, peritonitis, sepsis
  6. Usually affects the jejunum and ileum; the duodenum and colon are usually spared
  7. The change from congestion to infarction is gradual and the border between healthy and diseased bowel is less sharp than in arterial ischaemia
  8. Collaterals may develop in chronic MVT → cavernous transformation, varices

5. Classification

By cause

  • Primary (idiopathic), secondary (thrombophilia, local causes, stasis)

By course

  • Acute → sudden pain, risk of infarction
  • Subacute → weeks of vague pain, no infarction
  • Chronic → asymptomatic or portal hypertension (varices, splenomegaly, ascites)

By extent

  • Central (SMV trunk, portal vein, splenic vein) vs peripheral (small mesenteric veins and arcades)
  • Extension into the portal vein → portomesenteric thrombosis
Grid comparing arterial and venous mesenteric ischaemia
Diagram: arterial and venous mesenteric ischaemia compared

6. Clinical picture

Symptoms

  • Abdominal pain → central, colicky, then constant; more gradual onset than arterial AMI (days, sometimes 1–2 weeks); out of proportion to signs early
  • Anorexia, nausea, vomiting, diarrhoea or constipation
  • GI bleeding (haematemesis, melaena, haematochezia) in about 15–50%
  • History → previous DVT or PE (about half), family history, OCP, recent surgery, pancreatitis, cirrhosis

Signs

  • Early → mild tenderness, soft abdomen, distension
  • Fever, tachycardia
  • Ascites
  • Late → peritonism, shock (infarction)
  • Chronic → splenomegaly, varices, ascites (portal hypertension)

7. Diagnosis

Bloods

  • FBC (high haematocrit from dehydration; high WCC), lactate (late), U&E, LFT, amylase or lipase (pancreatitis), CRP, D-dimer (sensitive)
  • Clotting, blood cultures
  • Thrombophilia screen → ideally before or soon after starting heparin, but do not delay treatment (protein C, S and antithrombin fall during acute thrombosis and with anticoagulants; test after treatment ends if needed)
  • JAK2 V617F mutation, antiphospholipid antibodies, PNH flow cytometry
  • Look for an occult cancer (age-appropriate screening)

Imaging

  • CT with IV contrast in the portal venous phase (with arterial phase: biphasic) → investigation of choice (sensitivity over 90%):
    • Filling defect in the SMV or portal vein, enlarged vein with an enhancing rim (target sign)
    • Bowel wall thickening (often circumferential, "target" appearance), mesenteric oedema and fat stranding, dilated loops, ascites
    • Late signs → reduced wall enhancement, pneumatosis, portal venous gas, free gas
    • Collaterals and cavernous transformation (chronic)
  • Duplex ultrasound → portal and SMV thrombosis; less sensitive for the mesenteric veins
  • MR venography → alternative (pregnancy, contrast allergy)
  • Plain X-ray → non-specific (ileus, thumbprinting)
  • Diagnostic paracentesis → bloody ascites (not routine)
  • Angiography → only for interventional treatment (catheter-directed thrombolysis)
  • Upper GI endoscopy → varices (chronic)
Flowchart for mesenteric venous thrombosis
Diagram: mesenteric venous thrombosis, from CT to anticoagulation, intervention or surgery

8. Differential diagnosis

  • Arterial AMI (embolism or thrombosis), NOMI
  • Acute pancreatitis (may cause MVT)
  • Small bowel obstruction, strangulation
  • Inflammatory bowel disease, infectious enteritis
  • Perforated peptic ulcer, cholecystitis, appendicitis
  • Portal vein thrombosis from other causes (cirrhosis, cancer)
  • Budd-Chiari syndrome (hepatic veins)

9. Treatment

Conservative

  • Anticoagulation is the mainstay → start IV unfractionated heparin (or LMWH) as soon as the diagnosis is made, even with GI bleeding (bleeding is rarely a contraindication)
    • Unfractionated heparin preferred if surgery is likely (short half-life, reversible)
    • Prevents spread, allows recanalisation; avoids surgery in most (about 80–90% need no bowel resection)
  • Supportive care → bowel rest (NBM), NG tube, IV fluids, electrolytes, analgesia, broad-spectrum antibiotics (translocation), catheter
  • Serial clinical examination and lactate; repeat CT if not improving
  • Treat the cause → pancreatitis, sepsis, stop the OCP, haematology referral (myeloproliferative disease)
  • Long-term anticoagulation (warfarin or a DOAC):
    • 3–6 months for a reversible cause (surgery, pancreatitis, OCP)
    • Lifelong for thrombophilia, myeloproliferative neoplasms, recurrent or unexplained (idiopathic) MVT
    • DOACs are increasingly used (not in antiphospholipid syndrome or advanced cirrhosis)
  • Endovascular treatment → for patients without peritonitis who worsen despite anticoagulation:
    • Catheter-directed thrombolysis (via the SMA or transhepatic or transjugular access to the portal vein)
    • Mechanical thrombectomy, TIPS with thrombectomy
    • Higher bleeding risk; specialist centres
  • Chronic MVT → anticoagulation if a prothrombotic state is found; manage varices like portal hypertension (beta-blockers, banding, TIPS for refractory bleeding)

Surgical

  • Indications → peritonitis, perforation, signs of bowel infarction on CT or clinically, deterioration despite anticoagulation
  • Laparoscopy or laparotomy:
    • Continue heparin during and after surgery
    • Findings → dark, swollen, congested bowel; bloody ascites; pulsating arteries (unlike arterial ischaemia) but thrombosed veins
    • Resect only clearly necrotic bowel, with margins (the border is often indistinct; the thrombus can extend into the margins)
    • Primary anastomosis if stable, or ends left closed
    • Second-look laparotomy at 24–48 hours (planned at the first operation) → maximises bowel preserved
  • Venous thrombectomy of the SMV → rarely; for acute central thrombosis, with heparin, in selected centres
  • Temporary abdominal closure if the bowel is very oedematous (risk of abdominal compartment syndrome)

10. Complications

Of the disease

  • Bowel infarction, perforation, peritonitis, sepsis, death
  • GI bleeding
  • Stricture of the bowel after healing (late obstruction)
  • Portal hypertension → oesophageal and gastric varices, splenomegaly, ascites (chronic or portal extension)
  • Recurrent thrombosis (other sites too: DVT, PE)

Of treatment

  • Bleeding on anticoagulation or after thrombolysis
  • Short bowel syndrome after large resection
  • Anastomotic leak, heparin-induced thrombocytopenia

Prognosis

  • 30-day mortality 10–30%; better than arterial AMI
  • Long-term outcome depends on the cause (cancer, cirrhosis, myeloproliferative disease); 5-year survival in chronic MVT about 80%

Mind map Pinch or scroll to zoom · drag to move

Show as a list

Mesenteric venous thrombosis

  • Causes
    • Thrombophilia
    • JAK2, OCP, cancer
    • Pancreatitis
    • Splenectomy, cirrhosis
  • Features
    • Younger patients
    • Gradual pain
    • Bleeding 15-50%
    • Ascites
  • Tests
    • Portal venous CT
    • SMV filling defect
    • Thick bowel wall
    • Thrombophilia screen
  • Treatment
    • Heparin first
    • Bowel rest, antibiotics
    • Thrombolysis if worse
    • Surgery if infarcted
  • Long term
    • 3-6 months if reversible
    • Lifelong if thrombophilia
    • Varices, recurrence

More in State exam